ALCAM gene predicts breast cancer prognosis
This article was originally published in Clinica
A new gene for breast cancer that can predict the tumour's aggressiveness could help doctors better tailor therapy for women suffering from the disease.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.